Patient-Friendly Explanation

Amylin analogues are a class of medications that mimic amylin, a natural hormone the pancreas releases alongside insulin after meals. They slow stomach emptying, reduce appetite, and help control blood sugar — making them useful for both diabetes and weight management. Pramlintide is the best-known example currently available.

Clinical Definition

Amylin analogues are synthetic versions of the pancreatic β-cell hormone amylin (islet amyloid polypeptide), which is co-secreted with insulin. They act on the area postrema in the brainstem to promote satiety, delay gastric emptying, and suppress postprandial glucagon secretion. In clinical trials, pramlintide produced modest but sustained weight loss of 2-3 kg above placebo when used as monotherapy, and ongoing research is evaluating combination therapy with GLP-1 receptor agonists for synergistic effects.

Why It Matters

While GLP-1 agonists have received most attention, amylin analogues offer an alternative hormonal target. They work through a different pathway and can be particularly helpful for patients whose primary challenge is post-meal hunger or rapid gastric emptying. NuLifeCare Singapore includes amylin biology in its comprehensive hormonal assessment of each patient’s weight struggle.